NASDAQ
Intra-Cellular Therapies, Inc. (ITCI) has a current ratio of 6.36x as of Tuesday, May 26, 2026. This represents a 39.15% decrease compared to its 12-month average of 10.44x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.